Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. Shaun Boothe and “The Unauthorized Biography Series” is a ...
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 ...
SACRAMENTO, CALIF. — Biotechnology company One Bio has raised $27 million in a Series A funding round led by Alpha Edison. The round also had such new investors as DSM-Firmenich, Leaps by ...
Vancouver-based Aspect Biosystems has raised a $115-million USD ($165 million CAD) Series B round to realize its ambitions of bringing 3D-printed tissue therapies into clinical use. Aspect has ...
In Joseph McBride’s biography of Capra ... he was pitched a TV series entitled It’s Still a Wonderful Life, a sequel project with original stars Jimmy Stewart and Donna Reed playing their ...
B.R. Ambedkar Biography: Bhimrao Ramji Ambedkar, also known as B.R. Ambedkar, was born in Mhow, India, on April 14, 1891. Every year, April 14 is designated as Ambedkar Jayanti. Look into his ...
Atishi Marlena, a dynamic politician from the Aam Aadmi Party, has risen to prominence with her leadership in Delhi's education sector. As the newly elected Chief Minister of Delhi, she has ...
Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that ...
--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in B Cell Medicines (BCMs), today announced the closing of its $92M Series C financing. The round includes participation ...
A physician and entrepreneur with over 30 years of life sciences experience, Dr. Pruzanski previously served as Chairman and CEO of Versanis Bio (acquired by Eli Lilly) and was the founder and CEO of ...
New Anglo/U.S. obesity and cardiometabolic specialist Verdiva Bio Ltd. has launched with a massive $411 million series A and a portfolio of GLP-1 and amylin agonists in-licensed from China. Verdiva ...